Shandong Pharmaceutical Glass Co Ltd
SSE:600529
EV/IC
Enterprise Value to IC
Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.
Market Cap | EV/IC | ||||
---|---|---|---|---|---|
CN |
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
18.8B CNY | 2.9 | |
CH |
Alcon AG
SIX:ALC
|
39.4B CHF | 1.7 | ||
JP |
Hoya Corp
TSE:7741
|
6.8T JPY | 10.4 | ||
DK |
Coloplast A/S
CSE:COLO B
|
187.5B DKK | 4.4 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
20.9B USD | 3.9 | ||
US |
Cooper Companies Inc
NYSE:COO
|
19.1B USD | 1.9 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
12.3T KRW | 19.4 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
60.5B CNY | 12.2 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 39.1 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 1.1 | ||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 4.9 |
EV/IC Forward Multiples
Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.